InspireMD Inc

NSPR

Company Profile

  • Business description

    InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

  • Contact

    6303 Waterford District Drive
    Suite 215
    MiamiFL33126
    USA

    T: +1 888 776-6804

    https://www.inspiremd.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    127

Stocks News & Analysis

stocks

ASX energy giant undervalued despite commissioning challenges

Near-term hurdles, long-term upside.
stocks

Undervalued ASX share upgrades guidance

Market share gains drive earnings upgrade despite a weak US housing backdrop.
stocks

ASX major bank drives strong quarterly profit

Profit momentum remains robust yet shares overvalued.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,047.1014.800.16%
CAC 408,406.0633.780.40%
DAX 4025,361.03262.031.04%
Dow JONES (US)52,210.08262.830.51%
FTSE 10010,781.7545.520.42%
HKSE25,227.2920.110.08%
NASDAQ24,932.0843.74-0.18%
Nikkei 22562,046.462,884.73-4.44%
NZX 50 Index13,864.4513.760.10%
S&P 5007,413.181.200.02%
S&P/ASX 2008,883.6021.400.24%
SSE Composite Index3,818.3539.89-1.03%

Market Movers